Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1098 (LINC01098) is a human long non-coding RNA (lncRNA) located on chromosome 4q34.3, spanning bases 177,728,757 to 178,029,066 on the forward strand[3][5][7]. As a lncRNA, LINC01098 does not encode a protein but likely participates in the regulation of gene expression, similar to other lncRNAs, which can act at transcriptional, post-transcriptional, or epigenetic levels[1][7]. Its specific biological functions, mechanism of action, and involvement in disease processes remain uncharacterized in current literature. There are no known drugs, approved biomarkers, or explicit safety concerns associated with LINC01098 as of the available data. No evidence supports its use as a therapeutic target, and it is not considered a classical receptor, enzyme, transporter, or transcription factor[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1098 (LINC01098).